Mount Sinai scientists and physicians created a personalized fly model to treat a patient with terminal colon cancer; now she has a fighting chance
Esquire Magazine's article entitled "Patient Zero," describes Mount Sinai's pioneering Personalized Cancer Therapy program with a compelling story of patient Stephanie Lee. The article discusses how Eric Schadt, Ph.D. the Jean C. and James W. Crystal Professor of Genomics and our team at the Icahn Institute for Genomics and Multiscale Biology worked very closely with scientists and physicians at Mount Sinai to pioneer a new method of cancer treatment that could be a complete game-changer, using big data analysis, predictive networks, fly models and other cutting-edge techniques.
Mount Sinai Researchers Identify Molecular Changes in the Brain that May Increase Risk for Multiple Sclerosis
November 25, 2013 - First genome-wide study in brain tissue from MS patients.
Mount Sinai Researcher Shares 2013 American Society of Human Genetics Leadership Award With Research Partner Wife
November 4, 2013 - Kurt Hirschhorn, MD, and Rochelle Hirschhorn, MD, receive Victor McKusick Leadership Award.
Berg and Icahn School of Medicine at Mount Sinai Announce R and D Partnership
October 10, 2013 - Innovative Big Data Approach to Focus on Biological Network Models for Cancer, Central Nervous System and Endocrine Disorders.